• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX 2.09% $19.53

TELIX PHARMACEUTICALS LIMITED - Corporate Spotlight

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).More

No Corporate Spotlight currently available.

(20min delay)
Last
$19.53
Change
0.400(2.09%)
Mkt cap ! $6.465B
Open High Low Value Volume
$19.20 $19.54 $19.15 $9.465M 489.6K

Buyers (Bids)

No. Vol. Price($)
9 531 $19.53
 

Sellers (Offers)

Price($) Vol. No.
$19.54 1630 9
View Market Depth
Last trade - 12.56pm 22/07/2024 (20 minute delay) ?
Last
$19.64
  Change
0.400 ( 3.53 %)
Open High Low Volume
$19.19 $19.64 $19.16 188973
Last updated 13.16pm 22/07/2024 ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.